In a time of confusing terminology, one thing is clear: what the industry used to consider exceptional is now considered essential.
Hybrid. Decentralized. Remote. Digital. Virtual. Companies use these terms interchangeably. There is inconsistency, over-hyping, over-promising, confusion and a notable lack of substance. To be honest, it’s a bit like the Wild West out there.
Pharma15 Live! jumped at the chance to hear SnapIoT’s Ed Triebell discuss his company’s ground-breaking product, a software platform which allows users to seamlessly connect any smart device to any mobile device—and to any cloud.
Pharma15 Live! simply could not resist speaking with Jae Chung, founder of the “Turbo Tax for clinical trials start-up,” goBalto - and his furry friend, the Siberian Husky puppy aptly named Balto. Chung discussed his company’s mission to automate the laborious manual processes related to clinical trial start-up.
Georgia Mitsi spoke with BBK Worldwide®’s Aaron Fleishman about her company’s newest app E.V.A — an engagement platform for patients who suffer from chronic neurological conditions. Says Mitsi: “It’s about evaluate, validate and act.”
During this year’s DPharm 2018, Pharma15 Live! met up with Hassan Kadhim, senior associate director and head of IT clinical trial planning and management at Boehringer Ingelheim, before his presentation on the company’s novel remote clinical trial in the respiratory space. Kadhim reflected about the huge changes that he’s seen in the industry just in the past year.